Slow-binding reversible inhibitor of acetylcholinesterase with long-lasting action for prophylaxis of organophosphate poisoning
Open Access
- 6 October 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-12
Abstract
Organophosphorus (OP) compounds represent a serious health hazard worldwide. The dominant mechanism of their action results from covalent inhibition of acetylcholinesterase (AChE). Standard therapy of acute OP poisoning is partially effective. However, prophylactic administration of reversible or pseudo-irreversible AChE inhibitors before OP exposure increases the efficiency of standard therapy. The purpose of the study was to test the duration of the protective effect of a slow-binding reversible AChE inhibitor (C547) in a mouse model against acute exposure to paraoxon (POX). It was shown that the rate of inhibition of AChE by POX in vitro after pre-inhibition with C547 was several times lower than without C547. Ex vivo pre-incubation of mouse diaphragm with C547 significantly prevented the POX-induced muscle weakness. Then it was shown that pre-treatment of mice with C547 at the dose of 0.01 mg/kg significantly increased survival after poisoning by 2xLD50POX. The duration of the pre-treatment was effective up to 96 h, whereas currently used drug for pre-exposure treatment, pyridostigmine at a dose of 0.15 mg/kg was effective less than 24 h. Thus, long-lasting slow-binding reversible AChE inhibitors can be considered as new potential drugs to increase the duration of pre-exposure treatment of OP poisoning.Keywords
Funding Information
- Russian Science Foundation (19-15-00344)
- Ministry of Education and Science of the Russian Federation (theme no AAAA-A18-118040390114-8)
This publication has 58 references indexed in Scilit:
- Treatment of Myasthenia GravisClinical Drug Investigation, 2011
- Different sensitivities of rat skeletal muscles and brain to novel anti‐cholinesterase agents, alkylammonium derivatives of 6‐methyluracil (ADEMS)British Journal of Pharmacology, 2011
- Long‐lasting target binding and rebinding as mechanisms to prolongin vivodrug actionBritish Journal of Pharmacology, 2010
- Effectiveness of Donepezil, Rivastigmine, and (±)Huperzine A in Counteracting the Acute Toxicity of Organophosphorus Nerve Agents: Comparison with GalantamineThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Management of acute organophosphorus pesticide poisoningThe Lancet, 2008
- Early Death Due to Severe Organophosphate Poisoning Is a Centrally Mediated ProcessAcademic Emergency Medicine, 2003
- Early Death Due to Severe Organophosphate Poisoning Is a Centrally Mediated ProcessAcademic Emergency Medicine, 2003
- Acetylcholinesterase density and turnover number at frog neuromuscular junctions, with modeling of their role in synaptic functionNeuron, 1994
- Huperzine A as a pretreatment candidate drug against nerve agent toxicityLife Sciences, 1994
- Estimation of Cholinesterase Activity (EC 3.1.1.7; 3.1.1.8) in Undiluted Plasma and Erythrocytes as a Tool for Measuring In Vivo Effects of Reversible InhibitorsClinical Chemistry and Laboratory Medicine (CCLM), 1988